Overview

The Adjunctive Ventricular Arrhythmia Suppression Trial (AVAST) Pilot

Status:
Completed
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to learn if combination therapy with amiodarone and ranolazine (an approved drug for chest pain) can help prevent arrhythmias.
Phase:
N/A
Details
Lead Sponsor:
Hartford Hospital
Collaborator:
Gilead Sciences
Treatments:
Amiodarone
Ranolazine